Latest Results from Adult Tobacco Survey Conducted by Chinese CDC

News by 2FIRSTS.ai
Nov.20.2023
Latest Results from Adult Tobacco Survey Conducted by Chinese CDC
China CDC released the latest results of its adult tobacco survey, showing a smoking rate of 24.1% in 2022.

The latest findings from a tobacco survey conducted by the China Center for Disease Control and Prevention (China CDC) were unveiled at a meeting on November 13.

 

According to the data, the smoking rate among individuals aged 15 and above in 2022 was 24.1%, maintaining a downward trend. However, the smoking rate among males remains alarmingly high at 45.3%, while that among females is significantly lower at 2.3%.

 

The Deputy Director of the Office of Tobacco Control at the Chinese Center for Disease Control and Prevention, Xiao Lin, has revealed that this survey began in July last year and was completed in May this year due to the pandemic. The study focused on Chinese residents aged 15 and above who do not live in collective residences, involving 200,000 people from 31 provinces and 630 monitoring points. The survey included information on tobacco use, e-cigarette use, smoking cessation, secondhand smoke exposure, and prices. In terms of specific data, the age group of 15-24 showed the largest decrease in smoking rates, which aligns with the results of the national survey on tobacco use among adolescents.

 

However, the daily cigarette consumption among smokers is on the rise. According to the data, the number of cigarettes smoked per day increased from 16 in 2018 to 16.8 in 2022. When broken down, men smoke an average of 17 cigarettes per day, while women smoke 13.8 cigarettes. Among the age group of 45-64, the highest cigarette consumption is recorded, with individuals smoking an average of 18.4 cigarettes per day.

 

Several sets of data related to smoking cessation show positive trends. According to a survey, both the intention and attempted quitting rate among smokers have increased: 6.9% of smokers plan to quit smoking within one month, 14.7% plan to quit within 12 months, and 23.8% of smokers reported attempting to quit in the past 12 months. "Overall, it seems that smokers are putting quitting on the agenda and taking action," said Xiao Lin.

 

Meanwhile, the smoking cessation rate among individuals aged 15 and above has risen from 20.1% in 2018 to 22.4% in 2022. In terms of specific demographics, women exhibit a higher smoking cessation rate compared to men, while individuals aged 65 and above demonstrate the highest rate of quitting smoking.

 

It should be noted that quitting smoking is not solely reliant on personal determination, as nicotine addiction is actually a chronic disease. Smokers who seek standardized treatment in smoking cessation clinics can increase their success rate by 1-2 times. Xiao Lin introduced that individuals can search for the "China Smoking Cessation Platform" mini-program on WeChat to find detailed information about smoking cessation hotlines and clinics in all 31 provinces.

 

Data related to secondhand smoke has also shown improvement. A survey found that in 2022, the exposure rate to secondhand smoke among non-smokers aged 15 and above was 52.4%, a decrease of 15% compared to 2018. The exposure rates in government offices, healthcare institutions, indoor workplaces, public transportation, restaurants, universities, and homes have all significantly decreased. "Overall, the situation regarding secondhand smoke has improved," said Xiaolin.

 

However, some experts present at the conference believe that the decline in the data might be attributed to the strict epidemic prevention measures implemented last year. As the prevention measures restricted smokers from smoking in various public spaces, the actual smoking rate will need to be observed over the next few years to determine its long-term impact.

 

Several data points are displaying less-than-ideal performance. Despite strict regulations on tobacco advertising, a survey has found that the proportion of the public being exposed to tobacco marketing information is actually increasing. The data reveals that the percentages of individuals encountering tobacco advertisements in retail stores and online stand at 73.5% and 55.5%, respectively, indicating insufficient regulatory enforcement.

 

Meanwhile, the proportion of people aware of the dangers of tobacco is also declining. For example, in 2022, the proportion of people aged 15 and above who are aware that smoking causes lung cancer is 71.2%, a decrease from previous years. The awareness rate of secondhand smoke causing adult lung cancer is 62.8%, also a decrease from previous years. "It would be best to have health warnings on cigarette packaging that are visible to all smokers. This would be the most effective approach, but currently, we don't see this happening," said Xiao Lin.

 

It should be noted that although the smoking rate has continued to decline, there is still a significant gap from the smoking control targets set by the country. The "Healthy China 2030" plan outlined the goal of reducing the smoking rate among individuals aged 15 and above to 20% by 2030. As the deadline approaches, smoking control experts widely hope for increased policy efforts to promote tobacco control initiatives.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Malaysia health minister says court conviction over vape promotion sets key precedent for Act 852 enforcement
Malaysia health minister says court conviction over vape promotion sets key precedent for Act 852 enforcement
Malaysia’s Health Minister Datuk Seri Dr Dzulkefly Ahmad said the Putrajaya Magistrate’s Court decision to convict a known personality for promoting vape has set an important legal precedent for enforcing the Control of Smoking Products for Public Health Act (Act 852).
Jan.09 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Report Says Teen e-cigarette use on the rise, with majority of sales coming from disposable products
Report Says Teen e-cigarette use on the rise, with majority of sales coming from disposable products
Monitoring a Changing Tobacco Product Market in the United States is the second annual review from the Monitoring Tobacco Product Use project, analyzing retail scanner data from January 2019 to December 2024 and TEEN+ survey data.
Jan.07 by 2FIRSTS.ai
HB337 Moves Forward: Cigarette and Nicotine Taxes Set to Rise in Utah
HB337 Moves Forward: Cigarette and Nicotine Taxes Set to Rise in Utah
Utah lawmakers are advancing HB337, a bill that would raise the state cigarette tax by $2 per pack and restructure taxes on other nicotine products. The proposal replaces weight-based taxes with percentage-based rates and removes reduced rates for certain modified risk products. Supporters say it will curb youth tobacco use, while opponents warn of cross-border shopping and harm to consumers seeking alternatives.
Feb.17
Product | Full-screen display and 10K puffs: IVG launches new Pro-series pod vape in the UK
Product | Full-screen display and 10K puffs: IVG launches new Pro-series pod vape in the UK
E-cigarette brand IVG has recently rolled out the IVG Pro 2 across several UK online retailers. The device is compatible with IVG Pro pods and comes in 33 flavours with nicotine strengths of 0mg, 10mg and 20mg. Channel listings show a 2ml prefilled pod paired with a 10ml refill container, with pricing around £9.99.
Feb.02 by 2FIRSTS.ai
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11